Üst Gastrointestinal Sistem Kanaması Şeklinde Prezente olan Dev Gastrointestinal Stromal Tümör

Gastrointestinal stromal tümörler (GIST) gastrointestinal sistemin en sık görülen mezenkimal kaynaklı tümörleridir ve genellikle mide ve ince barsaktan köken alırlar. Her ne kadar küçük çapları nedeniyle klinik olarak sessiz iseler de, çapları 1-2 milimetreden birkaç santimetreye kadar ulaşabilir. GIST’lerin standart tedavisi cerrahidir, ancak hastanın risk durumuna göre bir tirozin kinaz inhibitörü olan imatinib de adjuvant tedavide kullanılabilir. Biz bu vaka raporunda üst gastrointestinal sistem kanaması ile prezente olan dev mide GIST’li bir hastaya sunmayı amaçladık. Hastaya, endoskopik stabilizasyon sonrası başarılı bir cerrahi tedavi uygulandı.

Giant Gastrointestinal Stromal Tumour Presented with Upper Gastrointestinal System Bleeding

Gastrointestinal stromal tumours (GIST) are the most common mesenchymal tumors of the gastrointestinal tract and they usually originate from stomach and small intestine. Although, these tumours are clinically silent because of their small size, their size can range from 1-2 milimeters to several centimeters. Standard therapy for GISTs is surgical treatment, and adjuvant treatment with tyrosine kinase inhibitors such as imatinib, depends on risk stratification. In this case report, we describe a-fifty-eight year old woman who presented with upper gastrointestinal system bleeding with a giant GIST of the stomach. After endoscopic stabilization of bleeding, the patient underwent a successful surgical operation with en bloc resection of the tumoural mass.

Kaynakça

1. Joensuu H, et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol. 2002 ;3:655-64.

2. Öfkeli Ö, et al. Karaciğer hemanjiomunu taklit eden dev mide gastrointestinal stromal tümörü. Causapedia. 2015;4:1138.

3. Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol. 1983;7:507-19.

4. Iorio N, Sawaya RA, Friedenberg FK. Review article: the biology, diagnosis and management ofgastrointestinal stromal tumours. Aliment Pharmacol Ther. 2014;39:1376-86.

5. DeMatteo RP, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51-8.

6. Demetri GD, et al. NCCN Task Force Report: Update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010; 8: S1-S44

7. Mora HF, et al. Gastrointestinal stromal tumor of the stomach and hepatocellular carcinoma: An unusual association. Int J Surg Case Reports. 2015;12:75-7.

8. Buluş H, et al. Stomach located giant GIST which obstructed the intestinal segment. J Clin Analytical Med. 2013;4:511-13.

9. Meesters B, et al. Metastasis in a benign duodenal stromal tumour. Eur J Surg Oncol. 1998;24:334-5.

10. Bucher P, et al. An audit of surgical management of gastrointestinal stromal tumours (GIST). Eur J Surg Oncol. 2006;32:310-4.

11. ESMO / European Sarcoma Network Working Group. Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23 Suppl 7:vii49-55.

Kaynak Göster